APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Non-Steroidal Anti-Inflammatory Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Research Report 2026

28 December 2025127 pages

Choose your research edition.

Industry ResearchDermatological Non-Steroidal Anti-Inflammatory Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dermatological Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs include LEAD CHEMICAL, Merck KGaA, Verona Pharma, Arcutis, GlaxoSmithKline PLc, Huadong Medicine, Pfizer Inc., Roche and MSD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Company

LEAD CHEMICAL

Merck KGaA

Verona Pharma

Arcutis

GlaxoSmithKline PLc

Huadong Medicine

Pfizer Inc.

Roche

MSD

Genzyme Co.

Shapuaisi

Sato Pharmaceutical

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Type

Ketotifen

Ketoconazole

Phthalin Butan

Tacrolimus

Prednisone

Loratadine

Cyclosporine A

Others

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Application

Hospital

Clinic

Others

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Non-Steroidal Anti-Inflammatory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Non-Steroidal Anti-Inflammatory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Dermatological Non-Steroidal Anti-Inflammatory Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Dermatological Non-Steroidal Anti-Inflammatory Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Dermatological Non-Steroidal Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units) of Manufacturers (2021-2026) Table 7. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Dermatological Non-Steroidal Anti-Inflammatory Drugs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Product Type & Application Table 14. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. LEAD CHEMICAL Company Information Table 19. LEAD CHEMICAL Business Overview Table 20. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 22. LEAD CHEMICAL Recent Developments Table 23. Merck KGaA Company Information Table 24. Merck KGaA Business Overview Table 25. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 27. Merck KGaA Recent Developments Table 28. Verona Pharma Company Information Table 29. Verona Pharma Business Overview Table 30. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 32. Verona Pharma Recent Developments Table 33. Arcutis Company Information Table 34. Arcutis Business Overview Table 35. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 37. Arcutis Recent Developments Table 38. GlaxoSmithKline PLc Company Information Table 39. GlaxoSmithKline PLc Business Overview Table 40. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 42. GlaxoSmithKline PLc Recent Developments Table 43. Huadong Medicine Company Information Table 44. Huadong Medicine Business Overview Table 45. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 47. Huadong Medicine Recent Developments Table 48. Pfizer Inc. Company Information Table 49. Pfizer Inc. Business Overview Table 50. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 52. Pfizer Inc. Recent Developments Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 57. Roche Recent Developments Table 58. MSD Company Information Table 59. MSD Business Overview Table 60. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 62. MSD Recent Developments Table 63. Genzyme Co. Company Information Table 64. Genzyme Co. Business Overview Table 65. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 67. Genzyme Co. Recent Developments Table 68. Shapuaisi Company Information Table 69. Shapuaisi Business Overview Table 70. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 72. Shapuaisi Recent Developments Table 73. Sato Pharmaceutical Company Information Table 74. Sato Pharmaceutical Business Overview Table 75. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 77. Sato Pharmaceutical Recent Developments Table 78. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2021-2026) & (Units) Table 80. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2021-2026) Table 81. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2027-2032) & (Units) Table 82. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2027-2032) Table 83. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2021-2026) Table 85. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2027-2032) Table 87. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 89. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 90. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 94. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 95. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 99. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 100. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 104. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 105. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 109. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 110. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 113. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 114. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2021-2026) Table 115. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2027-2032) Table 116. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2021-2026) Table 119. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2027-2032) Table 120. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2026) & (US$/Unit) Table 121. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2027-2032) & (US$/Unit) Table 122. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 123. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 124. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2021-2026) Table 125. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2027-2032) Table 126. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2021-2026) Table 129. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2027-2032) Table 130. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2026) & (US$/Unit) Table 131. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors List Table 135. Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers List Table 136. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Trends Table 137. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Drivers Table 138. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Image Figure 5. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (2021-2032) & (Units) Figure 8. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Average Price (US$/Unit) & (2021-2032) Figure 9. Ketotifen Product Image Figure 10. Ketoconazole Product Image Figure 11. Phthalin Butan Product Image Figure 12. Tacrolimus Product Image Figure 13. Prednisone Product Image Figure 14. Loratadine Product Image Figure 15. Cyclosporine A Product Image Figure 16. Others Product Image Figure 17. Hospital Product Image Figure 18. Clinic Product Image Figure 19. Others Product Image Figure 20. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Dermatological Non-Steroidal Anti-Inflammatory Drugs Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region in 2025 Figure 26. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region in 2025 Figure 27. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country in 2025 Figure 28. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 29. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2021-2032) Figure 30. United States Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Mexico Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country in 2025 Figure 34. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 35. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2021-2032) Figure 36. Germany Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Russia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Spain Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Netherlands Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Switzerland Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Sweden Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Poland Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country in 2025 Figure 47. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 48. Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2021-2032) Figure 49. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Japan Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South Korea Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. India Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Australia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Taiwan Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country in 2025 Figure 58. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 59. South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2021-2032) Figure 60. Brazil Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Argentina Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Chile Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country in 2025 Figure 64. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2021-2032) Figure 66. Egypt Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2021-2032) Figure 72. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2021-2032) Figure 73. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2021-2032) Figure 74. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2021-2032) Figure 75. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2021-2032) Figure 76. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2021-2032) Figure 77. Dermatological Non-Steroidal Anti-Inflammatory Drugs Value Chain Figure 78. Dermatological Non-Steroidal Anti-Inflammatory Drugs Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Ketotifen
  • Ketoconazole
  • Phthalin Butan
  • Tacrolimus
  • Prednisone
  • Loratadine
  • Cyclosporine A
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • LEAD CHEMICAL
  • Merck KGaA
  • Verona Pharma
  • Arcutis
  • GlaxoSmithKline PLc
  • Huadong Medicine
  • Pfizer Inc.
  • Roche
  • MSD
  • Genzyme Co.
  • Shapuaisi
  • Sato Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size (2021-2032)
  4. 2.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (2021-2032)
  5. 2.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Average Price (2021-2032)
  6. 2.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Ketotifen
  9. 2.3.3 Ketoconazole
  10. 2.3.4 Phthalin Butan
  11. 2.3.5 Tacrolimus
  12. 2.3.6 Prednisone
  13. 2.3.7 Loratadine
  14. 2.3.8 Cyclosporine A
  15. 2.3.9 Others
  16. 2.4 Dermatological Non-Steroidal Anti-Inflammatory Drugs by Application
  17. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  18. 2.4.2 Hospital
  19. 2.4.3 Clinic
  20. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, Established Date
  9. 3.9 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 LEAD CHEMICAL
  2. 4.1.1 LEAD CHEMICAL Company Information
  3. 4.1.2 LEAD CHEMICAL Business Overview
  4. 4.1.3 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  6. 4.1.5 LEAD CHEMICAL Recent Developments
  7. 4.2 Merck KGaA
  8. 4.2.1 Merck KGaA Company Information
  9. 4.2.2 Merck KGaA Business Overview
  10. 4.2.3 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  12. 4.2.5 Merck KGaA Recent Developments
  13. 4.3 Verona Pharma
  14. 4.3.1 Verona Pharma Company Information
  15. 4.3.2 Verona Pharma Business Overview
  16. 4.3.3 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  18. 4.3.5 Verona Pharma Recent Developments
  19. 4.4 Arcutis
  20. 4.4.1 Arcutis Company Information
  21. 4.4.2 Arcutis Business Overview
  22. 4.4.3 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  24. 4.4.5 Arcutis Recent Developments
  25. 4.5 GlaxoSmithKline PLc
  26. 4.5.1 GlaxoSmithKline PLc Company Information
  27. 4.5.2 GlaxoSmithKline PLc Business Overview
  28. 4.5.3 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  30. 4.5.5 GlaxoSmithKline PLc Recent Developments
  31. 4.6 Huadong Medicine
  32. 4.6.1 Huadong Medicine Company Information
  33. 4.6.2 Huadong Medicine Business Overview
  34. 4.6.3 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  36. 4.6.5 Huadong Medicine Recent Developments
  37. 4.7 Pfizer Inc.
  38. 4.7.1 Pfizer Inc. Company Information
  39. 4.7.2 Pfizer Inc. Business Overview
  40. 4.7.3 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  42. 4.7.5 Pfizer Inc. Recent Developments
  43. 4.8 Roche
  44. 4.8.1 Roche Company Information
  45. 4.8.2 Roche Business Overview
  46. 4.8.3 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  48. 4.8.5 Roche Recent Developments
  49. 4.9 MSD
  50. 4.9.1 MSD Company Information
  51. 4.9.2 MSD Business Overview
  52. 4.9.3 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  54. 4.9.5 MSD Recent Developments
  55. 4.10 Genzyme Co.
  56. 4.10.1 Genzyme Co. Company Information
  57. 4.10.2 Genzyme Co. Business Overview
  58. 4.10.3 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  60. 4.10.5 Genzyme Co. Recent Developments
  61. 4.11 Shapuaisi
  62. 4.11.1 Shapuaisi Company Information
  63. 4.11.2 Shapuaisi Business Overview
  64. 4.11.3 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  66. 4.11.5 Shapuaisi Recent Developments
  67. 4.12 Sato Pharmaceutical
  68. 4.12.1 Sato Pharmaceutical Company Information
  69. 4.12.2 Sato Pharmaceutical Business Overview
  70. 4.12.3 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  72. 4.12.5 Sato Pharmaceutical Recent Developments
5 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Scenario by Region
  1. 5.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2027-2032
  5. 5.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Value Chain Analysis
  2. 8.1.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Production Mode & Process
  5. 8.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors
  8. 8.2.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers
9 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Analyzing Market Dynamics
  1. 9.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Trends
  2. 9.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Drivers
  3. 9.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Opportunities and Challenges
  4. 9.4 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst